- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fascia in New Zealand
Total 60 results
-
Noema Pharma AGRecruitingTrigeminal NeuralgiaUnited States, Denmark, Germany, Italy, Spain, United Kingdom, Turkey, Poland
-
The Radiosurgery SocietyVisionTreeRecruitingNeoplasms | Trigeminal Neuralgia | Arteriovenous Malformation of Central Nervous SystemUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterEnrolling by invitation
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); University College, London; McMaster University and other collaboratorsCompletedHead and Neck Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States, Canada, United Kingdom
-
Cytrellis Biosystems, Inc.CompletedWrinkle | Facial and Neck Skin LaxityUnited States
-
Santen Inc.Vistakon PharmaceuticalsTerminatedCorneal TransplantationUnited States
-
AO Clinical Investigation and Publishing DocumentationAOCMFCompletedMandibular FracturesQatar, United States, Germany, South Africa, Finland, Spain, Malaysia, Romania, Ukraine
-
Global Healthy Living FoundationUniversity of Alabama at BirminghamRecruitingHeart Failure | Stroke | Epilepsy | Multiple Sclerosis | Obesity | Diabetes | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Rheumatoid Arthritis | Parkinson Disease | Peripheral Arterial Disease | Inflammatory Bowel Diseases | Amyotrophic Lateral Sclerosis | Psoriasis | Asthma | Muscular Dystrophy | Fibromyalgia | Alzheimer... and other conditionsUnited States
-
Avidity Biosciences, Inc.RecruitingPhase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, United Kingdom, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada